Skip to main content
. Author manuscript; available in PMC: 2020 May 19.
Published in final edited form as: Cancer Biol Ther. 2009 Aug 1;8(15):1440–1449. doi: 10.4161/cbt.8.15.9133

Table 1.

Partial list of current and potential targets for cancer vaccine therapy

Carcinoma-associated antigens Endogenous Retroviral gene products Leukemia/lymphoma antigens Melanoma antigens Viral antigens
Brachyury HERV-H Aberrant class II MAGE HPV
CA125 HERV-K Anti-idiotype MART
CEA B1 gp100
EGFR CD19 Tyrosinase
HER-2/neu CD20 CD2
KSA CD22 CD3
Mesothelin CD25 GM2
MUC-1 CD36
NY-ESO
p53
PAGE-4
PAP
PSA
PSCA
PSMA
Ras
sTn
TARP
VEGF